Durvalumab Interactions
There are 624 drugs known to interact with durvalumab, along with 11 disease interactions. Of the total drug interactions, 25 are major, 598 are moderate, and 1 is minor.
- View all 624 medications that may interact with durvalumab
- View durvalumab disease interactions (11)
Most frequently checked interactions
View interaction reports for durvalumab and the medicines listed below.
- Adderall XR (amphetamine / dextroamphetamine)
- Alimta (pemetrexed)
- Aspirin Low Strength (aspirin)
- Augmentin (amoxicillin / clavulanate)
- Benadryl (diphenhydramine)
- Brovana (arformoterol)
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- Dulera (formoterol / mometasone)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flovent HFA (fluticasone)
- Gemzar (gemcitabine)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Iron Sulfate (ferrous sulfate)
- Keytruda (pembrolizumab)
- MethylPREDNISolone Dose Pack (methylprednisolone)
- Metoprolol Succinate ER (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Morphine Sulfate ER (morphine)
- Morphine Sulfate IR (morphine)
- Pepcid AC (famotidine)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Spiriva Respimat (tiotropium)
- Stiolto Respimat (olodaterol / tiotropium)
- Symbicort (budesonide / formoterol)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Durvalumab disease interactions
There are 11 disease interactions with durvalumab which include:
- adrenal insufficiency
- colitis
- diabetes
- infections
- liver dysfunction
- renal dysfunction
- thyroid disorders
- Durvalumab – pneumonitis
- HSCT
- myasthenia gravis
- organ transplant
Report options
More about durvalumab
- durvalumab consumer information
- Compare alternatives
- Reviews (7)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Cisplatin
Cisplatin systemic is used for anal cancer, bladder cancer, blood cell transplantation, bone marrow ...
Pembrolizumab
Pembrolizumab (Keytruda) is a monoclonal antibody cancer medicine used to treat
Medroxyprogesterone
Medroxyprogesterone (Provera) treats conditions such as absent or irregular menstrual periods, or ...
Methotrexate
Methotrexate is used to treat certain types of cancer of the breast, skin, head and neck, or lung ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
